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Abstract
Background: Endothelial nitric oxide synthase (eNOS) has previously been detected in the
glandular part of the human gastric mucosa. Furthermore, nitric oxide (NO) has been shown to
influence gastric secretion in various animal models. The present study was conducted to
investigate the influence of exogenously and endogenously derived NO on histamine- and cAMP-
stimulated gastric acid secretion in isolated human oxyntic glands.
Methods: Oxyntic glands were isolated from human gastric biopsies and were subsequently pre-
treated with NO donors and nitric oxide synthase inhibitors and then exposed to histamine or
dibutyryl-cAMP (db-cAMP). The secretory response of the glands was determined as accumulation
of [14C]aminopyrine.
Results: The histamine- or db-cAMP-induced acid secretion was attenuated by L-arginine, a known
source of endogenous NO, and also by the NO-donors sodium nitroprusside (SNP) and S-nitroso-
N-acetyl-penicillamine (SNAP). Pre-treatment with either of the NOS inhibitors NG-nitro-L-
arginine methyl ester (L-NAME) or NG-nitro-L-arginine (L-NNA) enhanced the secretory
response.
Conclusion: Our results show that NO inhibits gastric acid secretion in isolated human gastric
glands, and that there is endogenous formation of NO within the glandular epithelium in the vicinity
of the parietal cells.
Background
Nitric oxide (NO) is produced from L-arginine in a reac-
tion catalyzed by the enzyme nitric oxide synthase
(NOS)[1,2]. NO is an important biological signalling
molecule that influences circulation by regulating vascu-
lar smooth muscle tone and modulating systemic blood
pressure. Furthermore, NO is involved in neurotransmis-
sion; it is a critical factor in the inflammatory response
and immunity [3-5]; and it has been shown to exert posi-
tive effects on mucosal defence in the gastrointestinal sys-
tem. In several studies (for review, see [6]), chemically
induced mucosal damage seemed to be reduced by simul-
taneous addition of NO and impaired by removal of NO
from the gastric mucosa. An explanation for those find-
ings might be that NO increases mucosal blood flow[7],
and it has been suggested that NO augments the release of
mucus[8]. It is likely that NO is also involved in the regu-
lation of other secretory processes in the gastrointestinal
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system. Takeuchi and co-workers [9] have reported that
NO inhibits the secretion of duodenal bicarbonate,
whereas other investigators have proposed that bicarbo-
nate secretion is stimulated by NO [10,11]. In addition,
several studies have indicated that NO affects the secre-
tion of gastric acid [12-16].
Animal experiments have provided conflicting informa-
tion about the interaction between NO and gastric acid
secretion. For instance, studies in vitro have shown that
NO stimulates secretion of gastric acid in the
mouse[17,18] and bullfrog[19]. In addition, similar
results have been obtained in dogs [12]. However, other
investigations have shown that NO inhibits gastric acid
secretion in the rat [13,14], in gastric glands isolated from
rabbits [15], and in mucosa from toads [16]. Studies of
humans have provided data indicating that NO can both
inhibit and augment intragastric pH [20,21], but it is not
yet known how this compound participates in gastric acid
secretion in humans.
In an earlier study, we found morphological support that
endogenous NO plays a role in regulation of parietal cell
function [22]. Also, the immunohistochemical data from
that investigation revealed the presence of endogenous
NOS in epithelial cells of the normal human oxyntic
mucosa, more precisely, in both surface mucous cells and
endocrine cells. In addition, we observed that there were
close contacts between eNOS-positive cells and parietal
cells either because the eNOS-positive cells contacted
parietal cells via cytoplasmic processes or were invagi-
nated by a parietal cell. Based on these findings, together
with the chemical properties of NO, we concluded that
NO derived from the endocrine-like cells might be a para-
crine regulator of gastric acid secretion. In the present
study, our aim was to verify the effect of exogenous NO on
histamine- and cAMP-stimulated gastric acid secretion in
humans, and also to determine whether endogenously
derived NO has a functional effect on human parietal
cells.
Methods
Subjects and ethical approval
Twenty-four healthy men ranging in age from 22 to 31
years were recruited as paid volunteers. The selection cri-
teria stipulated that the subjects had to be free from dis-
ease and should not have taken any medications or
imbibed alcohol for at least one week prior to examina-
tion. The men fasted for at least six hours before
examination.
Pharyngeal anaesthesia was induced with lidocaine spray
(Xylocain®, AstraZeneca, Södertälje, Sweden), after which
routine gastroscopy was performed using an Olympus
GIF-100 endoscope. Pinch biopsy forceps (Olympus FB
24K-1) were used to take tissue specimens from the
greater curvature, immediately distal to the fundus. In all
subjects, the gastric mucosa appeared to be normal, both
macroscopically and histologically. All subjects tested
negative for Helicobacter pylori infection in the urease
breath test (Diabact® UBT 50 mg 13C-urea, Diabact AB,
Uppsala, Sweden).
The experimental procedures were approved by the
Regional Ethics Committee for Human Research at Uni-
versity Hospital, Linköping, Sweden (File no. 02-039),
and all subjects gave informed consent.
Secretory study
Isolation and incubation of gastric glands
The current experiments were based on a technique that
was first described in 1976 for use in rabbits in vitro [23]
and is now well established for indirect determination of
gastric acid secretion induced by various stimuli. The
method of isolating gastric glands was initially developed
for animal tissue, but it was later refined so that it could
also be applied to small amounts of human tissue [24].
The human oxyntic mucosal biopsies used in our study
were washed and stored no longer than 15 minutes in ice-
cold oxygenated phosphate-buffered saline (PBS). The tis-
sue specimens were cut into smaller pieces with a pair of
scissors and transferred to oxygenated (100% O2) colla-
genase enzyme solution (130.0 mM NaCl, 12.0 mM
NaHCO3, 3.0 mM Na2HPO4, 3.0 mM K2HPO4, 2.0 mM
MgSO4, 1.0 mM CaCl2, 0.1 mM N(alfa)-tosyl-L-lysine chlo-
romethyl ketone [TLCK], 10 µM indomethacin, 10 mM
glucose, 2 mg/ml human serum albumin [HSA; Sigma],
and 1 mg/ml collagenase type IA [Sigma]). The mixture
was placed in a 37°C water bath and was gently stirred for
120 minutes, after which most of the treated specimen
had disintegrated, leaving mainly isolated gastric glands.
The mixture was subsequently filtered through a 200 µm
mesh. The isolated glands were washed and re-suspended
in pre-warmed (37°C) respiratory medium (132.4 mM
NaCl, 1.0 mM NaH2PO4, 1.2 mM MgSO4, 5.4 mM KCl,
5.0 mM Na2HPO4, 1.0 mM CaCl2, 10 µM indomethacin,
10 mM glucose, and 2 mg/ml HSA). The glands were then
transferred to vials containing fresh respiratory medium
to which we added one of the following: the NOS inhibi-
tor NG-nitro-L-arginine methyl ester (L-NAME; 1 mmol/L)
or equivalent amounts of its biologically inactive enanti-
omer NG-nitro-D-arginine methyl ester (D-NAME); the
NOS inhibitor NG-nitro-L-arginine (L-NNA; 0.1 mmol/L);
either of the two NO donors sodium nitroprusside (SNP;
1 mmol/l) and S-nitroso-N-acetyl-penicillamine (SNAP;
0.1 mmol/L); the substrate for endogenous NO produc-
tion, L-arginine (0.1 mmol/L) [15]. All gland suspensions,
including those that were not stimulated, were incubated
in a shaking water bath at 37°C for 30 minutes, afterBMC Gastroenterology 2004, 4:16 http://www.biomedcentral.com/1471-230X/4/16
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which we added histamine to a final concentration of 50
µmol/L or dibutyryl-cAMP (db-cAMP) to a final concen-
tration of 1 mmol/L. To prevent degradation of cyclic
nucleotides, we added 0.1 mmol/L 3-isobutyl-1-methylx-
antine (IBMX) to all stimulations.
Determination of the [14C]aminopyrine accumulation ratio
A well-established method used to indirectly measure acid
secretion by isolated gastric glands is to determine accu-
mulation of 14C-labeled aminopyrine (AP) in the glands
themselves and in the supernatant after centrifugation
and then calculate the ratio between those two values
(called the AP ratio) [23]. In short, acid secretion was
stimulated at 37°C for 40 minutes, and after that 0.5 µCi
[14C]labeled aminopyrine was added to the vials, which
were then further incubated at 37°C for 90 minutes.
Thereafter, the gland suspension was transferred to previ-
ously dried and weighed tubes, which were centrifuged at
4,000 rpm for two minutes. The supernatant was removed
and transferred to scintillation vials. The pellets (glands)
were dried at 100°C, and the dry weight was determined,
and the glands were subsequently re-suspended in 0.5
mol/L NaOH at 60°C and transferred to scintillation
vials. The radioactivity of the glands and the supernatant
was determined in a liquid scintillation counter (1214
Rackbeta, LKB), and the AP ratio was calculated using the
following formula[24]:
where IGW is intraglandular water volume (= 2 × the dry
weight of glands in mg).
Background accumulation of AP is included in the values
representing the secretory response. The AP ratios for
background and histamine-and db-cAMP-stimulated con-
ditions differed between the individuals. Therefore, for
each subject, we determined the AP ratio for stimulated
glands and considered that value to be 100% and used it
as an individual reference value. All values are based on
single analyses.
Statistics
Data were analysed by one-sample sign tests comparing
median values using MINITAB™ Statistical Software. P val-
ues less than 0.05 were considered significant.
Immunohistochemistry
Isolated gastric glands from five test subjects were placed
on charged Super Frost*/Plus glass slides (Menzel-Gläser,
Germany) and then washed with PBS and permeabilized
with 100% ethanol at -70°C for 5 min. Thereafter, the
slides were incubated at room temperature overnight with
rabbit anti-NOS3 antibody (1:1000; Santa Cruz Biochem-
icals) and then washed thoroughly in PBS and incubated
for 1 h with biotinylated goat anti-rabbit secondary anti-
body. Slides where primary antibody had been left out
served as negative controls. The slides were subsequently
washed again, and biotinylated antibody was detected by
exposure to 20 µg/ml Texas Red® Avidin (Vector Laborato-
ries) for 1 h. Following that treatment, the slides were
washed and coverslipped using Vectashield® mounting
medium. A Nikon Eclipse® E800 fluorescence microscope
with a VFM EPI-fluorescence attachment was used to
examine and evaluate the slides. A band-pass filter with a
wavelength range of 520–560 nm and a long-pass filter
with cut-on wavelength at 590 nm (for emitted light) were
employed to visualize the Texas Red® molecules.
Hematoxylin and eosin staining
For morphological evaluation, glands were fixed on glass
slides and stained with Harris hematoxylin for five min-
utes and 0.5% eosin Y for two minutes. Each step was fol-
lowed by a rinse in tap water.
Results
We studied the effects of NO on acid secretion induced by
various stimulants in gastric glands isolated from stomach
biopsies from human. Morphological examination of the
hematoxylin-eosin-stained slides revealed that the isola-
tion procedure had successfully yielded whole-gland
preparations and that parietal cells were present in the
gastric glands. Immunohistochemical analysis showed
that the isolated glands contained eNOS-immunoreactive
cells (Fig. 1), which agrees with results obtained using
other types of mucosal preparations [22]. Control experi-
ments were primary antibody was excluded showed no
immunoreactivity.
Background AP-accumulation
Background AP accumulation was observed in the iso-
lated glands, with a median AP ratio of 8.6 (range 2.5–
22.1; n = 19). After administration of 50 µmol/L of hista-
mine or 1 mmol/L of db-cAMP, the median AP ratios were
24.7 (5.8–64.5; n = 16) and 38.2 (range 7.6–47.8; n = 11)
respectively. The response to both histamine and db-
cAMP exceeded the background by a factor of about 2–4
in all preparations (Figs. 2 and 3).
Effect of NO donors and NOS inhibitors on histamine-
stimulated gastric acid secretion
Pre-treatment of isolated glands with the exogenous NO
donor SNP (1 mmol/L) reduced the histamine response
to a median of 48% (n = 7) of the response seen in non-
pre-treated glands (100%). In four out of five gland prep-
arations, the substrate for endogenous NO formation, L-
arginine (0.1 mmol/L), decreased the AP ratio. This effect
however was not statistically significant (Fig. 2a). When
14
14
C  cpm in glands/IGW
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isolated glands were pre-treated with NOS inhibitor L-
NAME (1 mmol/L), and then exposed to histamine, the
AP ratio was markedly elevated to a median value of
147% (n = 13). Although a small number of individuals
were tested, L-NNA (0.1 mmol/L) yielded a similar result;
172% (n = 2). By comparison, in control experiments, the
L-NAME analogue D-NAME (1 mmol/L) had no effect at
all on histamine-stimulated acid secretion (Fig. 2b).
Effect of NO donors and NOS inhibitors on db-cAMP-
stimulated gastric acid secretion
Exposing the isolated glands to db-cAMP increased the
secretion of gastric acid compared to the background
level. Compared to untreated glands, those that were pre-
treated with SNP (1 mmol/L) or SNAP (0.1 mmol/L)
accumulated less AP after stimulation with db-cAMP;
63%(n = 9) and 81%(n = 8) respectively (Fig. 3a). More-
over, similar to histamine-stimulated secretion, the db-
cAMP-induced secretion was increased to a median of
152% (n = 9) in glands that had been pre-treated with L-
NAME (1 mmol/L). Although no effect on L-arginine on
histamine-stimulated acid secretion could be seen, there
was a significant effect of L-arginine on db-cAMP-induced
secretion. Acid output was inhibited to a median of 77%
(n = 10) in those pre-treated with L-arginine (0.1 mmol/
L)(Fig. 3b).
Discussion
The method of using isolated gastric glands in vitro is well
suited for studying the interaction between gastric acid
secretion and various endocrine signals. This technique
has been thoroughly evaluated, chiefly in experiments on
Immunofluorescence of an isolated gastric gland Figure 1
Immunofluorescence of an isolated gastric gland. Immunolocalization of eNOS (arrowheads) in a gastric gland isolated 
from human oxyntic mucosa was achieved using a rabbit anti-eNOS polyclonal antibody. The results were visualized with 
Texas Red®-conjugated goat anti-rabbit IgG. Bar = 30 µm.BMC Gastroenterology 2004, 4:16 http://www.biomedcentral.com/1471-230X/4/16
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Accumulation of 14C-labeled aminopyrine in histamine-stimulated gastric glands Figure 2
Accumulation of 14C-labeled aminopyrine in histamine-stimulated gastric glands. All values are expressed as per-
cent of the gastric acid secretion induced by histamine (considered to be 100%), which was calculated separately for gastric 
glands isolated from each of the healthy volunteers. Each symbol represents the results for one individual. a) Accumulation of 
14C-aminopyrine in glands pretreated with the NO donor sodium nitroprusside (SNP, 1 mmol/L) or with L-arginine (0.1 mmol/
L), the substrate for endogenous NO production. It can be seen that SNP markedly reduced AP accumulation (median = 48%; 
p < 0.05), which indicates that NO inhibits acid secretion from the isolated glands. Background 14C-aminopyrine accumulation 
(bg) is also shown. b) Accumulation of 14C-aminopyrine in gastric glands pretreated with the NOS inhibitors L-NNA (0.1 
mmol/L) and L-NAME (1 mmol/L), respectively. L-NAME caused increased accumulation (median = 147%; p < 0.05), which sug-
gests that acid secretion is elevated when endogenous NO production is prevented, indicating an inhibitory role for endog-
enous NO in human gastric glands. D-NAME, which is the biologically inactive stereo isomer of L-NAME, did not have an effect 
on acid secretion, and it was therefore used as a control substance.
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Accumulation of 14C-labeled aminopyrine in db-cAMP-stimulated gastric glands Figure 3
Accumulation of 14C-labeled aminopyrine in db-cAMP-stimulated gastric glands. All values are expressed as per-
cent of a value representing the gastric acid secretion induced by db-cAMP (considered to be 100%), which was calculated sep-
arately for each of the studied subjects. Each symbol represents the data for one individual. a) Pretreatment with SNP (median 
= 63%; p < 0.05) or SNAP (median = 81%; p < 0.05) to release exogenous NO before adding db-cAMP to stimulate acid secre-
tion reduced the accumulation of 14C-aminopyrine in gastric glands, as compared to levels of secretion seen in untreated 
glands. This indicates that NO can inhibit acid secretion in gastric glands isolated from humans. b) Treatment with L-NAME to 
inhibit NOS in the gastric glands increased the accumulation of 14C-aminopyrine after stimulation with db-cAMP (median = 
152%; p < 0.05). Those results indicate that NO inhibits db-cAMP-induced acid secretion. The NO substrate L-arginine 
reduced the accumulation of 14C-aminopyrine in db-cAMP-stimulated glands (median = 77%; p < 0.05). Background accumula-
tion (bg) is also shown.
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animals, and it has been reported to offer good
reproducibility [23]. Furthermore, in a study of gastric
glands isolated from stomach biopsies taken from
humans [24], it was found that both histamine and db-
cAMP induced secretory responses that were reproducible
when repeated using gland preparations from the same
subject, although there was considerable interindividual
variation. Fellenius et al. [24] and Haglund et al. [25] have
reported that both histamine and db-cAMP stimulated
gastric acid secretion from isolated human gastric glands,
and this was observed as a two- to threefold increase in AP
accumulation compared to the background level. Those
results agree with our data obtained using histamine and
db-cAMP. It is known that SNP releases NO [26], and in
our experiments SNP reduced secretion of gastric acid
from isolated glands. Hence, NO inhibits acid secretion in
isolated human gastric glands. Some of the effects of SNP
may be due to cytotoxic interactions, although no such
impact was found in a study of isolated rabbit gastric
glands [15]. To rule out the possibility of a cytotoxic influ-
ence, we performed complementary experiments using
the NO donor SNAP, which has chemical properties that
differ from those of SNP. In those experiments, we
observed the same reduction in AP accumulation after
stimulation with db-cAMP, which further favours the con-
clusion that NO is in fact responsible for observed results.
In db-cAMP-stimulated glands, the induced secretory
response was reduced by L-arginine, a compound that
depends on an endogenous factor (i.e., eNOS) to generate
NO, although that reduction was not as pronounced as
the decrease induced by SNP and SNAP. There are a
number of possible explanations for that observation. If
there was already enough L-arginine in the glands to sus-
tain NO production at the time of the experiment, addi-
tion of L-arginine was therefore without effect.
Furthermore, L-arginine may have had a weak impact
because the effect of NO occurred through up- or down
regulation of the enzyme NOS and was not influenced by
access to substrate. Notwithstanding, L-arginine did
decrease the accumulation of AP, albeit not as much as the
exogenous NO donors did at the present doses. This indi-
cates that some specific process is responsible for generat-
ing NO from L-arginine in isolated gastric glands. These
results are consistent with studies showing that SNP,
SNAP, and L-arginine inhibited histamine-stimulated acid
secretion from gastric glands isolated from animals
[13,15]. L-arginine has also been observed to reduce car-
bachol-stimulated acid secretion in toads [16].
In a previous study conducted by our research group [22],
examination of the glandular epithelium of specimens of
human oxyntic mucosa revealed that one particular type
of cells contained NOS. These eNOS-immunoreactive
cells, defined as endocrine cells, were in close contact with
parietal cells. These two characteristics suggest that cells of
this type release NO, which thus might be a paracrine reg-
ulator that directly affects the function of parietal cells.
That assumption may be supported by a number of other
conditions. For example, NO can easily penetrate cell
membranes, which may indicate an intracellular site of
action. Also, NO has a rather short life span, which
implies that sources needed to generate this oxide must be
available close to the NO target cell. In this study, the
occurrence of eNOS in the glands is shown, but earlier
extensive investigations using antibodies against both
nNOS and iNOS have not revealed presence of any of the
two isoforms in the glandular epithelium of normal
human subjects (unpublished observation). Similar to
results obtained in a study of isolated rabbit gastric
glands[15], we found that the NOS inhibitors L-NAME
and L-NNA, but not D-NAME, amplified the secretion-
stimulating effect of histamine, which further indicates
that the isolated human glands we used contained the
enzyme NOS. Both the increase in the AP ratio that we
observed following inhibition of NOS and the decrease in
secretory responses that we noted in glands treated with L-
arginine strengthen the hypothesis that NO is produced
by cells in the glandular epithelium and, when released, it
interferes with stimulated acid secretion. Interestingly, the
mentioned observations suggest that the release of NO is
sustained, regardless of whether acid secretion is stimu-
lated, which implies that NO functions as an endogenous
inhibitor of gastric acid secretion. The intensity of this
inhibition probably depends on the number of eNOS-
containing endocrine-like cells that are present in the
vicinity of the parietal cells.
The exact mechanisms behind this paracrine regulation of
gastric acid secretion is yet to be elucidated. There are sev-
eral different pathways within the parietal cell that might
be affected by NO. It can induce ADP ribosylation of G-
actin [27], thereby influencing the cytoskeleton. This
could be essential for the morphological changes that
parietal cells exhibit during acid secretion. Accordingly, if
NO does have a persistent impact on an element such as
the cytoskeleton, it might play a role in the membrane
recycling hypothesis proposed by Forte et al. [28]. Briefly,
that theory suggests that parietal cells undergo the
following morphological alterations: they have a large
active secretory surface during the stimulatory phase, and
they display a minimal active secretory surface during the
resting phase.
Since it is known that guanylate cyclase is a general target
of NO in many cell systems, some investigators have sug-
gested that NO exerts its effects via cyclic guanosine 3',5'-
monophosphate (cGMP) in both rat and rabbit parietal
cells [13,15]. An ongoing study in our laboratory will
show whether this is the case in human parietal cells.
Downstream effects of cGMP may include activation of aBMC Gastroenterology 2004, 4:16 http://www.biomedcentral.com/1471-230X/4/16
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number of effectors, such as ion channels, protein kinases,
and phosphodiesterases [29]. It is also plausible that NO
can exert its effect alone, without acting through other sig-
nalling molecules. Under experimental conditions, NO
can induce nitrosylation and nitration of cellular proteins,
although that is probably not the case in vivo, since those
two processes often result permanent damage to vital
functions [30]. There is a possibility that the suppression
of acid secretion occurs not only at parietal cell level, but
via other cell types. ECL-cells are probably present in the
glandular preparation and in the rat, these cells have the
ability to release histamine in response to increased intra-
cellular levels of cAMP [31]. NO can inhibit this hista-
mine-release [14] and thereby further contribute to the
inhibition of acid secretion. Although there is little known
about human ECL-cells and the effects of NO on hista-
mine-release there are studies that indicate species differ-
ences in other histamine-secreting cells. For example, rat
mast cells have been shown to produce an "NO-like fac-
tor" which inhibits histamine-release [32] while there are
investigations that indicate that NO does not affect hista-
mine-secretion in human basophils [33]. At present we
can only establish differences in inhibitory response to l-
arginine for histamine and db-cAMP stimulation.
Further investigations are needed to clarify the role of NO
in parietal cell function.
Conclusions
The findings of the present study suggest that NO pro-
duced endogenously in the human oxyntic mucosa can
reduce the stimulatory effects of histamine or db-cAMP on
gastric acid secretion. We obtained uniform results for gas-
tric glands isolated from different healthy human sub-
jects, which implies that NO released from specific cells
within the secretory mucosa plays an important physio-
logical role in the regulation of gastric acid secretion.
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